We confirmed REST splicing into inactive REST4 variants in NE-high SCLC and demonstrated that SMARCA4 inhibition with FHD-286 reduced the levels of inactive REST4 through downregulation of SRRM4. This evidence concerns the gene REST and small cell lung carcinoma.